CTLA4

Infection associated with immune checkpoint inhibitors

Immune Checkpoint Inhibitors (ICI) are used to treat malignancy (breast CA, bladder CA, cervical CA, lung CA, colon CA, Hodgkin lymphoma etc). There are three types of ICIs Type of ICIs Example Programmed death 1(PD-1) inhibitors Atezolizumab, Avelumab, Durvalumab Programmed death 1 ligand (PD-L1) inhibitors Nivolumab, Pembrolizumab, Cemiplimab, Dostarlimab cytotoxic T lymphocyte-associated antigen 4 (CTLA4) […]